To identify early molecular drivers in the establishment of BRCA1-deleted/mutated tumors, we generated iPSC lines from the peripheral blood mononuclear cells (PBMCs) of patients who carried a germline deletion of exon 17 of the BRCA1 gene and who, based on their family histories, were at a high risk for cancer. The gene discussed is BRCA1; the disease is cancer.